(Back to Case Studies)

Case Study: Prohemia® Increases Hemoglobin 66% in 6 Weeks

Prohemia® case study shows dramatic blood building effects in an 66-year-old male with anemia. He has a history of Chronic Lymphatic Leukemia and was treated with chemotherapy in 2009. In the summer of 2011 he was hospitalized and received multiple transfusions for anemia and continued to receive transfusions on an out-patient basis.

METHODS: A 66-year-old male with anemia agreed to participate in a case study to help demonstrate the efficacy of Prohemia® to support healthy blood levels. Six (6) Prohemia® capsules were ingested daily for 6 weeks. Hematocrit and hemoglobin levels were measured after six weeks of continuous Prohemia® use.

RESULTS: Following six weeks of Prohemia® use, the subject’s hematocrit and hemoglobin improved to healthy normal levels.

 

Hemoglobin
(grams/dL)

Hematocrit
(%)

Before Prohemia®

7.
(anemic)

21.8
(anemic)

After Prohemia®

12.0
(normal)

33.7
(normal)

CONCLUSION: Although limited to a single subject, this anemic subject showed dramatic improvements in blood levels at six(6) weeks. Specifically, hemoglobin levels increased 66% and hematocrit increased 65%. This anemic subject’s blood levels returned to healthy normal levels after two months of Prohemia® use.

This case study also agrees with previous published clinical studies that showed potent increases in erythropoietin (EPO) levels following ingestion of the ingredients found in Prohemia®.

 

*Results may vary and the case study results cannot be expected in 100% of Prohemia users.